[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2737971B1 - Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee - Google Patents

Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee

Info

Publication number
FR2737971B1
FR2737971B1 FR9510093A FR9510093A FR2737971B1 FR 2737971 B1 FR2737971 B1 FR 2737971B1 FR 9510093 A FR9510093 A FR 9510093A FR 9510093 A FR9510093 A FR 9510093A FR 2737971 B1 FR2737971 B1 FR 2737971B1
Authority
FR
France
Prior art keywords
elastine
vitamin
synthesis
derivatives
stimulate skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9510093A
Other languages
English (en)
Other versions
FR2737971A1 (fr
Inventor
Marc Dumas
Frederic Bonte
Alain Meybeck
Catherine Chaudagne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9510093A priority Critical patent/FR2737971B1/fr
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Priority to GB9708362A priority patent/GB2308811B/en
Priority to DE19680859T priority patent/DE19680859T1/de
Priority to CH00961/97A priority patent/CH690489A5/fr
Priority to JP51964796A priority patent/JP4313846B2/ja
Priority to PCT/IB1996/000444 priority patent/WO1996019099A2/fr
Priority to AU54077/96A priority patent/AU5407796A/en
Priority to US08/817,978 priority patent/US5801192A/en
Priority to CA002202629A priority patent/CA2202629A1/fr
Priority to BE9600701A priority patent/BE1009858A5/fr
Priority to IT96TO000710A priority patent/IT1284758B1/it
Priority to NL1003883A priority patent/NL1003883C2/nl
Publication of FR2737971A1 publication Critical patent/FR2737971A1/fr
Priority to ES009750014A priority patent/ES2129013B1/es
Application granted granted Critical
Publication of FR2737971B1 publication Critical patent/FR2737971B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9510093A 1995-08-25 1995-08-25 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee Expired - Lifetime FR2737971B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR9510093A FR2737971B1 (fr) 1995-08-25 1995-08-25 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
US08/817,978 US5801192A (en) 1995-08-25 1996-05-10 Use of vitamin C or derivatives or analogues thereof promoting skin elastin synthesis
CH00961/97A CH690489A5 (fr) 1995-08-25 1996-05-10 Utilisation de la vitamine C ou de ses dérivés ou analogues pour stimuler la synthèse de l'élastine cutanée.
JP51964796A JP4313846B2 (ja) 1995-08-25 1996-05-10 ビタミンｃ若しくはその誘導体又はそれらの類似体の，皮膚エラスチン合成促進のための使用
PCT/IB1996/000444 WO1996019099A2 (fr) 1995-08-25 1996-05-10 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
AU54077/96A AU5407796A (en) 1995-08-25 1996-05-10 Use of vitamin c or derivatives or analogues thereof for promoting skin elastin synthesis
GB9708362A GB2308811B (en) 1995-08-25 1996-05-10 Use of vitamin C or derivatives or analogues thereof for promoting skin elastin synthesis
CA002202629A CA2202629A1 (fr) 1995-08-25 1996-05-10 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
DE19680859T DE19680859T1 (de) 1995-08-25 1996-05-10 Verwendung von Vitamin C oder seiner Derivate oder Analoga zur Stimulierung der Synthese von Haut-Elastin
BE9600701A BE1009858A5 (fr) 1995-08-25 1996-08-19 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee.
IT96TO000710A IT1284758B1 (it) 1995-08-25 1996-08-20 Utilizzo della vitamina c o di suoi derivati o analoghi per stimolare la sintesi dell'elastina cutanea.
NL1003883A NL1003883C2 (nl) 1995-08-25 1996-08-26 Het gebruik van vitamine C of van zijn afgeleide of analoge verbindingen voor het stimuleren van de synthese van elastine in de huid.
ES009750014A ES2129013B1 (es) 1995-08-25 1997-04-25 Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9510093A FR2737971B1 (fr) 1995-08-25 1995-08-25 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee

Publications (2)

Publication Number Publication Date
FR2737971A1 FR2737971A1 (fr) 1997-02-28
FR2737971B1 true FR2737971B1 (fr) 1997-11-14

Family

ID=9482092

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9510093A Expired - Lifetime FR2737971B1 (fr) 1995-08-25 1995-08-25 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee

Country Status (13)

Country Link
US (1) US5801192A (fr)
JP (1) JP4313846B2 (fr)
AU (1) AU5407796A (fr)
BE (1) BE1009858A5 (fr)
CA (1) CA2202629A1 (fr)
CH (1) CH690489A5 (fr)
DE (1) DE19680859T1 (fr)
ES (1) ES2129013B1 (fr)
FR (1) FR2737971B1 (fr)
GB (1) GB2308811B (fr)
IT (1) IT1284758B1 (fr)
NL (1) NL1003883C2 (fr)
WO (1) WO1996019099A2 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768927B1 (fr) * 1997-10-01 2000-01-21 Lvmh Rech Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
FR2791261A1 (fr) * 1999-03-24 2000-09-29 Roche Posay Lab Pharma Utilisation de la vitamine c ou analogue pour promouvoir la transformation de procollagenes inactifs en collagenes actifs
FR2791259B1 (fr) * 1999-03-24 2001-08-17 Roche Posay Lab Pharma Utilisation de la vitamine c ou analogues pour augmenter le taux de differenciation et/ou de proliferation des cellules de la peau
US6184247B1 (en) * 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
FR2795956B1 (fr) * 1999-07-06 2006-07-14 Inst Evaluation Dermatophysiqu Composition cosmetique pour ameliorer l'elasticite de la peau et lutter contre son vieillissement
AU1701501A (en) * 1999-12-14 2001-06-25 Unilever Plc Cosmetic skin conditioning compositions containing red yeast rice extract
FR2807322B1 (fr) 2000-04-10 2004-02-20 Oreal Composition, notamment cosmetique, comprenant de l'acide ascorbique en association avec un derive d'acide ascorbique
FR2807320B1 (fr) * 2000-04-10 2002-05-24 Oreal Utilisation de derives d'acide ascorbique pour augmenter la synthese des creramides epidermiques
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
US6468552B1 (en) 2000-06-02 2002-10-22 Neutrogena Corporation Stabilized compositions containing oxygen-labile active agents
US6576248B1 (en) 2000-09-11 2003-06-10 Avon Products, Inc. Pigmented vitamin C composition
CN100361987C (zh) 2001-08-24 2008-01-16 马蒂亚斯·拉特 抗坏血酸化合物，合成方法及其应用
WO2003017942A2 (fr) * 2001-08-24 2003-03-06 Rath Matthias M D Derives uniques d'acide ascorbique comprenant des acides amines essentiels, des acides amines non essentiels et des acides amines non presents les proteines, procede de preparation et d'utilisation de ces derives dans la recherche, la medecine, la physiologie, la pharmacologie, la nutrition, les produits pharmaceutiques, ai
FR2832630B1 (fr) * 2001-11-28 2005-01-14 Oreal Composition cosmetique et/ou dermatologique contenant au moins un actif hydrophile sensible a l'oxydation stabilise par au moins un copolymere de n-vinylimidazole
KR100505105B1 (ko) * 2001-12-20 2005-07-29 샘즈바이오 주식회사 삼중 코팅구조의 비타민 에이씨(레티닐 팔미테이트와순수비타민 씨) 및 그를 함유하는 화장료 조성물
EP1374849B1 (fr) * 2002-06-20 2005-11-23 L'oreal Utilisation cosmétique et/ou dermatologique d'une composition contenant au moins un actif hydrophile sensible à l'oxydation stabilisé par au moins un copolymère d'anhydride maléique
FR2846005B1 (fr) * 2002-10-16 2006-06-23 Maco Pharma Sa Composition pour milieu biologique comprenant de l'erythorbate de sodium
AU2002353388A1 (en) * 2002-12-20 2004-07-14 Council Of Scientific And Industrial Research Herbal composition for cuts, burns and wounds
US7025966B2 (en) 2003-12-05 2006-04-11 Mary Kay Inc. Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
JP2005247826A (ja) * 2004-02-04 2005-09-15 Kose Corp デコリン産生促進剤及びそれを含有する皮膚外用剤
KR100868905B1 (ko) * 2004-03-26 2008-11-14 (주)아모레퍼시픽 진세노사이드 ｆ1과 ｅｇｃｇ을 함유한 자외선 조사로유도되는 피부손상 방지용 조성물
JP2009500394A (ja) * 2005-07-08 2009-01-08 ザ プロクター アンド ギャンブル カンパニー パーソナルケア組成物及び哺乳類の皮膚と毛髪を美化する方法
US20070077220A1 (en) * 2005-09-30 2007-04-05 Ramirez Jose E Stable ascorbic acid compositions
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
DE102006035040A1 (de) * 2006-07-28 2008-01-31 Beiersdorf Ag Wirkstoffkombinationen aus Ascorbylverbindung und hydriertem Lecithin
FR2911779B1 (fr) 2007-01-30 2009-04-24 Lvmh Rech Composition contenant un extrait d'ambre
IT1397735B1 (it) * 2010-01-18 2013-01-24 Binda Composizione cosmetica ad attivita' idratante ed antiossidante.
JP5679684B2 (ja) * 2010-03-17 2015-03-04 グンゼ株式会社 Ｄａｎｃｅタンパク質含有組織再生用基材
EP2484387A1 (fr) * 2011-02-03 2012-08-08 Q-Med AB Composition d'acide hyaluronique
US20130089641A1 (en) * 2011-10-11 2013-04-11 Sunway Biotech Co., Ltd. Soymilk with Additive of Vitamin C, Vitamin C salt or Vitamin C Stereoisomer
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
EP3072535B1 (fr) * 2015-03-26 2017-03-01 Université de Bordeaux Procédé de reconstruction de peau
ITUB20152183A1 (it) * 2015-07-15 2017-01-15 Germano Laghi Miscela di principi attivi cosmetici per la preparazione di un gel cosmetico e metodo per la preparazione di detto gel
KR102354282B1 (ko) * 2017-05-17 2022-01-21 주식회사 엘지생활건강 에리소르빈산을 포함하는 화장료 조성물
JP2019069912A (ja) * 2017-10-06 2019-05-09 株式会社シャネル化粧品技術開発研究所 非水系皮膚外用組成物およびその製造方法
WO2020081868A1 (fr) * 2018-10-18 2020-04-23 Baek Clinical Inc. Formulations topiques de vitamine c à dosage élevé

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5262635A (en) * 1975-11-20 1977-05-24 Matsushita Electric Ind Co Ltd Method of producing zinc electrode
JPS6379809A (ja) * 1986-09-22 1988-04-09 Shiseido Co Ltd 皮膚外用剤
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
EP0282746A1 (fr) * 1987-02-19 1988-09-21 Takeda Chemical Industries, Ltd. Procédé de préparation de tissu cultivé de manière artificielle
FR2612775B1 (fr) * 1987-03-25 1991-10-11 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
US4938969A (en) * 1988-11-14 1990-07-03 Milor Scientific, Ltd. Method for the treatment of aging or photo-damaged skin
FR2666226B1 (fr) * 1990-08-30 1994-10-28 Jean Noel Thorel Composition protectrice de la peau.
EP0537092A1 (fr) * 1991-10-08 1993-04-14 Patrinove Societe Civile Vecteurs vésiculaires infracellulaires et leurs applications dans les compositions cosmétiques, médicamenteuses et les milieux de culture
FR2717389B1 (fr) * 1994-03-18 1996-06-07 Lvmh Rech Utilisation du ginsénoside Ro ou d'un extrait végétal en contenant pour stimuler la synthèse du collagène.
DE4419783A1 (de) * 1994-06-06 1995-12-07 Asta Medica Ag Haarkur-Pflege-Shampoo
FR2735982B1 (fr) * 1995-06-27 1997-09-19 Lvmh Rech Composition cosmetique ou pharmaceutique contenant un extrait de plantes du genre filicium

Also Published As

Publication number Publication date
ITTO960710A1 (it) 1998-02-20
NL1003883C2 (nl) 1997-02-27
GB2308811A (en) 1997-07-09
WO1996019099A3 (fr) 1997-04-10
CH690489A5 (fr) 2000-09-29
WO1996019099A2 (fr) 1996-06-27
JP4313846B2 (ja) 2009-08-12
JPH10509735A (ja) 1998-09-22
ES2129013A1 (es) 1999-05-16
GB9708362D0 (en) 1997-06-18
IT1284758B1 (it) 1998-05-21
BE1009858A5 (fr) 1997-10-07
AU5407796A (en) 1996-07-10
CA2202629A1 (fr) 1996-06-27
DE19680859T1 (de) 1997-10-02
GB2308811B (en) 2000-04-05
GB2308811A8 (en) 1999-05-21
ES2129013B1 (es) 2000-04-01
FR2737971A1 (fr) 1997-02-28
US5801192A (en) 1998-09-01
NL1003883A1 (nl) 1997-02-27

Similar Documents

Publication Publication Date Title
FR2737971B1 (fr) Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
FR2680466B3 (fr) Preparation de blanchiment de la peau.
ID18944A (id) Metoda pemilihan sistem produk penyehatan wanita
FR2732594B1 (fr) Utilisation de derives d'acide salicylique pour la depigmentation de la peau
FR2694692B1 (fr) Préparation cosmétique de nutrition de la peau.
FR2614787B1 (fr) Cosmetique pour la peau
AR241097A1 (es) "producto de conservacion de la madera"
FR2767059B1 (fr) Utilisation d'extraits de polygonatum pour stimuler la synthese de l'elastine cutanee
IT8567279A1 (it) Apparecchio per l'applicazione controllata, sul tessuto umano, di sostanze riducenti per realizzare microabrasioni.
FI973124A (fi) D-vitamiinijohdannaisten dermatologinen käyttö
GB9601844D0 (en) Improvements in or relating to the detection of variations in human histamine H� receptors
FR2686503B1 (fr) Prothese de rehabilitation de la tete femorale.
FR2641463B1 (fr) Preparations cosmetiques destinees a l'oxygenation de la peau
FR2740344B1 (fr) Application de la proteine gax au traitement de cancers
FR2759906B1 (fr) Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques
IT1204664B (it) Macchina spruzzatrice principalmente per la dispersione di soluzione di spruzzatura proporzionatamente all'area
FR2758458B1 (fr) Produits cosmetiques ou dermo-pharmaceutiques respectant l'ecologie cutanee
FR2683455B1 (fr) Composition pour la stimulation de la synthese localisee des tissus conjonctifs.
FR2701397B1 (fr) Produit pour l'administration topique de substances médicamenteuses ou cosmétologiques.
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
FR2653335B3 (fr) Produit cosmetique hydratant pour l'epiderme.
RO94261A2 (fr) Produit medicamenteux pour le troublement de dynamique sexuelle
FR2712806B1 (fr) Préparation cosmétique pour l'éclaircissement de la peau.
IT8822378A0 (it) Dispositivo per l'espletamento di necessita' fisiologiche per persone di sesso femminile.
LV5178A3 (lv) Preparats "etogin" govju endometritu arstesanai